These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36741707)

  • 1. Eighteen years' experience with tumor treating fields in the treatment of newly diagnosed glioblastoma.
    Vymazal J; Kazda T; Novak T; Slanina P; Sroubek J; Klener J; Hrbac T; Syrucek M; Rulseh AM
    Front Oncol; 2022; 12():1014455. PubMed ID: 36741707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma.
    Miller R; Song A; Ali A; Niazi M; Bar-Ad V; Martinez N; Glass J; Alnahhas I; Andrews D; Judy K; Evans J; Farrell C; Werner-Wasik M; Chervoneva I; Ly M; Palmer J; Liu H; Shi W
    Front Oncol; 2022; 12():896246. PubMed ID: 35574391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor treating fields in glioblastoma: long-term treatment and high compliance as favorable prognostic factors.
    Wang J; Du Q; Chen J; Liu J; Gu Z; Wang X; Zhang A; Gao S; Shao A; Zhang J; Wang Y
    Front Oncol; 2024; 14():1345190. PubMed ID: 38571508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial.
    Ballo MT; Urman N; Lavy-Shahaf G; Grewal J; Bomzon Z; Toms S
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1106-1113. PubMed ID: 31026557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial.
    Ram Z; Kim CY; Hottinger AF; Idbaih A; Nicholas G; Zhu JJ
    Front Oncol; 2021; 11():671972. PubMed ID: 34692470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study.
    Ali AS; Lombardo J; Niazi MZ; Miller RC; Alnahhas I; Martinez NL; Andrews DW; Judy KD; Shi W
    J Neurooncol; 2022 Nov; 160(2):345-350. PubMed ID: 36355259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial.
    Kim CY; Paek SH; Nam DH; Chang JH; Hong YK; Kim JH; Kim OL; Kim SH
    J Neurooncol; 2020 Feb; 146(3):399-406. PubMed ID: 32020470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor treating fields for newly diagnosed high-grade glioma based on the criteria of 2021 WHO CNS5: A retrospective analysis of Chinese patients in a single center.
    Zhang L; Ren Y; Peng Y; Luo Y; Liu Y; Wang X; Yang Y; Liu L; Ai P; Yang X; Li Y; Mao Q; Wang F
    Cancer Med; 2024 Jun; 13(11):e7350. PubMed ID: 38859683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Treating Fields Combine with Temozolomide for Newly Diagnosed Glioblastoma: A Retrospective Analysis of Chinese Patients in a Single Center.
    Chen C; Xu H; Song K; Zhang Y; Zhang J; Wang Y; Sheng X; Chen L; Qin Z
    J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma.
    Song A; Bar-Ad V; Martinez N; Glass J; Andrews DW; Judy K; Evans JJ; Farrell CJ; Werner-Wasik M; Chervoneva I; Ly M; Palmer JD; Liu H; Shi W
    J Neurooncol; 2020 May; 147(3):653-661. PubMed ID: 32206976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of tumor-treating fields therapy for glioblastoma: A single-center study in a Chinese cohort.
    She L; Gong X; Su L; Liu C
    Front Neurol; 2022; 13():1042888. PubMed ID: 36698900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study.
    Bokstein F; Blumenthal D; Limon D; Harosh CB; Ram Z; Grossman R
    Front Oncol; 2020; 10():411. PubMed ID: 32373508
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis.
    Ballo MT; Conlon P; Lavy-Shahaf G; Kinzel A; Vymazal J; Rulseh AM
    J Neurooncol; 2023 Aug; 164(1):1-9. PubMed ID: 37493865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TTFields Prolonged the PFS of Epithelioid Glioblastoma Patient: A Case Report.
    Ding Y; Wang Q; Wang F; Wu N; Li J; He X; Pan H; Wang L
    Brain Sci; 2023 Apr; 13(4):. PubMed ID: 37190598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
    Ornelas AS; Porter AB; Sharma A; Knox MG; Marks LA; Wingerchuk DM; O'Carroll CB
    Neurologist; 2019 Mar; 24(2):71-73. PubMed ID: 30817495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
    Stupp R; Taillibert S; Kanner A; Read W; Steinberg D; Lhermitte B; Toms S; Idbaih A; Ahluwalia MS; Fink K; Di Meco F; Lieberman F; Zhu JJ; Stragliotto G; Tran D; Brem S; Hottinger A; Kirson ED; Lavy-Shahaf G; Weinberg U; Kim CY; Paek SH; Nicholas G; Bruna J; Hirte H; Weller M; Palti Y; Hegi ME; Ram Z
    JAMA; 2017 Dec; 318(23):2306-2316. PubMed ID: 29260225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete radiological response following subtotal resection in three glioblastoma patients under treatment with Tumor Treating Fields.
    Kessler AF; Linsenmann T; Westermaier T; Wolber W; Weiland J; Monoranu CM; Breun M; Hagemann C; Ernestus RI; Löhr M
    Oncol Lett; 2020 Jan; 19(1):557-561. PubMed ID: 31897171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.
    Taphoorn MJB; Dirven L; Kanner AA; Lavy-Shahaf G; Weinberg U; Taillibert S; Toms SA; Honnorat J; Chen TC; Sroubek J; David C; Idbaih A; Easaw JC; Kim CY; Bruna J; Hottinger AF; Kew Y; Roth P; Desai R; Villano JL; Kirson ED; Ram Z; Stupp R
    JAMA Oncol; 2018 Apr; 4(4):495-504. PubMed ID: 29392280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: durable response of gliomatosis cerebri with concurrent tumor-treating fields (TTFields) and chemoradiotherapy treatment.
    DesJarlais AM; Miller R; Ali AS; Niazi MZ; Cappelli L; Glass J; Farrell CJ; Shi W
    Chin Clin Oncol; 2023 Dec; 12(6):69. PubMed ID: 38195076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial.
    Guberina N; Pöttgen C; Kebir S; Lazaridis L; Scharmberg C; Lübcke W; Niessen M; Guberina M; Scheffler B; Jendrossek V; Jabbarli R; Pierscianek D; Sure U; Schmidt T; Oster C; Hau P; Grosu AL; Stuschke M; Glas M; Nour Y; Lüdemann L
    Radiat Oncol; 2020 Apr; 15(1):83. PubMed ID: 32307022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.